Room: President's Ballroom CD

Presenting Tuesday through Wednesday

Beth Israel Deaconess Medical Center
1.         Genome Editing with Third Generation Chemically Modified Oligonucleotides without Programmable Nucleases; Presented by Tod W.
Brigham and Women's Hospital
2.         Long Non-Coding RNA VIARS Regulates Vascular Inflammation and Atherosclerosis by Binding FXR1; Presented by Jacob P.
3.         Pharmacokinetic and Pharmacodynamic Imaging of Intrathecally Administered Antisense Oligonucleotides; Presented by Tom M.
Q-State Biosciences
4.         Antisense Oligonucleotide (ASO)-Mediated Rescue of Protein Expression in Fibroblasts and Neurons Derived from a Patient with a Rare, Autosomal Recessive Neurological Disorder Caused by Loss-of-Function Mutations in the TECPR2 Gene; Presented by Graham D.
5.         Characterization of Synthetic Oligonucleotides Using LC-MS and LC MS/MS; Presented by Baburaj K.
6.         Sensitive and Robust Plasmid Quality Analysis by Capillary Electrophoresis with Laser-Induced Fluorescence Detection; Presented by Matthew S.
7.         Improve Sensitivity for Quantification of Antisense Oligonucleotides in Plasma Using MicroLC-MRM; Presented by Yi Z.
Soonchunhyang University
8.         miRNA Signatures Differentially Expressed in Lung Cancer Cell-Derived Exosomes; Presented by Mi Young L.
University of Bordeaux
9.         Lipid Oligonucleotides as a New Strategy for Tackling the Antibiotic Resistance; Presented by Philippe B.
University of Tokyo
10.       Chemical Modification of siRNA Revealed that Its Seed Region Is Divided into Functionally Different Domains; Presented by Kumiko U.

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag

Oligonucleotide Discovery and Delivery